Close Menu

Bruker

NEW YORK (GenomeWeb) – With the launch last year of two US Food and Drug Administration-cleared mass spec microbiology platforms, microbe identification has emerged as one of clinical proteomics' most prominent success stories.

NEW YORK (GenomeWeb) – Saying that it does not believe its Chemical and Applied Markets division can achieve "acceptable financial performance" in the next two years, Bruker today said that it plans to sell and/or restructure certain parts of the CAM business, resulting in an expected 200 to 250

NEW YORK (GenomeWeb) – University of Victoria spinout firm MRM Proteomics said this week it has named as CEO Gary Kruppa, formerly Bruker's vice president for business development.

NEW YORK (GenomeWeb) – Saying a recent uptick in Bruker's share price represents a less favorable risk/reward profile, investment bank ISI Group today downgraded the company's stock to a Neutral rating.

NEW YORK (GenomeWeb) — Researchers from Virginia Commonwealth University have developed a method of quantifying multiple nucleic acid targets in a single sample by combining low-cycle-number, target-specific PCR with atomic force microscopy.

NEW YORK (GenomeWeb) – Bruker said today that it has received clearance from the China Food and Drug Administration to sell its IVD MALDI Biotyper as a medical device for the identification of microorganisms isolated from human specimens.

BALTIMORE (GenomeWeb News) – While triple quads predominated at last year's American Society for Mass Spectrometry annual meeting, high-resolution instruments were the focus of this year's gathering with several vendors launching new high-end QTOF or Q-Orbitrap machines.

BALTIMORE (GenomeWeb) – With the launch of a new crop of high-resolution instruments at the American Society for Mass Spectrometry annual conference here this week, vendor

New Products: ASMS Focus

Premium

A number of vendors introduced new proteomics products at the American Society for Mass Spectrometry meeting in Baltimore this week. The following is a roundup of new offerings introduced at the conference.

NEW YORK (GenomeWeb) – Wells Fargo Securities today upgraded shares of Bruker to an Outperform rating and increased the price range on its stock after a Bruker official said the company plans to further restructure its Chemical and Applied Markets division and grow its presence in the clinical ma

Pages

Australia will not be regulating gene editing of plants, animals, and human cell lines as long as no new genetic material is incorporated, reports Nature News.

The Washington Post reports that the US Department of Agriculture told its researchers to label peer-reviewed articles as "preliminary" work.

Researchers have sequenced the genomes of both the coast redwood and the giant sequoia, according to the San Francisco Chronicle.

In PNAS this week: study of epigenetic patterns in mammalian eggs, clonal expansion patterns in CD8+ T cells, and more.